Apostles in the New Testament

National Fund for Sacred Places Awards Grants to 16 Historically Significant Faith Communities Across the U.S.

Retrieved on: 
Monday, October 16, 2023
National Trust for Historic Preservation, First Bryan Baptist Church, St. Paul's Church, UT, Episcopal Church, The National Fund, Apostles in the New Testament, Partner, First Unitarian Church, St. Mark's, Lutheranism, Interim, Trust, Shrine, CT, Unitarian Universalist Church of Buffalo, Architecture, Partners for Sacred Places, St Paul's Cathedral, National Trust, Unitarian church, Tourism, Lace

PHILADELPHIA, Oct. 16, 2023 /PRNewswire/ -- The National Fund for Sacred Places, a program of Partners for Sacred Places in collaboration with the National Trust for Historic Preservation, is pleased to announce its 2023 grantees.

Key Points: 
  • PHILADELPHIA, Oct. 16, 2023 /PRNewswire/ -- The National Fund for Sacred Places, a program of Partners for Sacred Places in collaboration with the National Trust for Historic Preservation, is pleased to announce its 2023 grantees.
  • Sixteen historically significant faith communities have been admitted into the prestigious program, which provides capital grants of up to $250,000 and hands-on technical assistance to congregations undertaking significant preservation projects.
  • "We are delighted to welcome 16 faith communities from around the United States into the National Fund.
  • The National Fund for Sacred Places is made possible thanks to the generosity of Lilly Endowment Inc.

Gene Switch Global Market Report 2023: Numerous Positive Breakthroughs Draw the Attention of Key Pharmaceutical Players - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 27, 2023
Biotechnology, Genetics, Health, ACT, Graft-versus-host disease, DNA, Partnership, GVHD, Apostles in the New Testament, CRS, Oxygen, CPC, Overalls, Clinical trial, Enzyme, Cell proliferation, Light, DSM-IV codes, Toxicity, Research, Infection, Attention, Gene expression, RNA, Element, TCR, II, Organization, Sangamo Therapeutics, US, TILS, Protein, Cytokine release syndrome, Investment, Patent, Plasmid, OFF, III, Gene, Neurotoxicity, Oligonucleotide, Safety, Geography, Agriculture, Pharmaceutical industry, Vaccine, Video game, Fine chemical, Retail

The report features an extensive study of the current market landscape and future opportunity for the players involved in the development of gene switch.

Key Points: 
  • The report features an extensive study of the current market landscape and future opportunity for the players involved in the development of gene switch.
  • The global gene switch market is anticipated to grow at an annualized growth rate (CAGR) of 14% during the period 2023-2035.
  • Further, North America is anticipated to capture the major share of the gene switch market in 2035.
    Who are the Key Players in the Gene Switch Market?
  • Answer: The global gene switch market is expected to grow at a CAGR of 14%, during the period 2023-2035.

Hope is on the horizon for a malaria-free Africa

Retrieved on: 
Monday, April 24, 2023
Vaccine, RTS, Tuberculosis, Human, United Nations, Parasitism, Apostles in the New Testament, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Public, R21, COVID-19, Biting, History, Research, Goal, Antibody, Death, Climate change, AIDS, Animal, Investment, United, Risk, Maharashtra University of Health Sciences, Drug combination, Horn, Anopheles, Plasmodium falciparum, WHO, World, Disease, World Health Organization, Pharmaceutical industry, Tea, Malaria, Earth

The progress made between 2000 and 2015 is proof of what can be achieved.

Key Points: 
  • The progress made between 2000 and 2015 is proof of what can be achieved.
  • Support from global donors helped drive down malaria deaths among children under five from 723,000 to 306,000.
  • Fifty-five of the 106 malaria-endemic countries showed a 75% decrease in new malaria cases by 2015 compared to 2000.
  • Malaria cases and deaths increased as national malaria control programmes competed with other health challenges.
  • The World Health Organization (WHO) and other partners issued urgent calls to address the challenges national programmes were facing.

History

    • One of the goals was to reduce the malaria burden by 75% by 2015.
    • Encouraged by the progress in rolling back malaria, the WHO launched the Global Technical Strategy for Malaria.
    • Unfortunately, the release of this strategy coincided with a levelling off in domestic and international funding, which led to an uptick in malaria cases.

Setbacks

    • Climate change experts predict that as the Earth warms up, malaria will spread into malaria-free areas.
    • And that malaria transmission rates in areas where the disease is currently will increase.
    • It has mutated and can go undetected by the most widely used point-of-care diagnostic tool in rural malaria endemic regions.
    • Read more:
      Some malaria parasites are evading detection tests, causing an urgent threat to public health

Way ahead

    • A newer version of the RTS,S vaccine, the R21 vaccine produced by Oxford University’s Jenner Institute, has shown much high efficacy in a Phase III trial.
    • This has prompted Ghana and Nigeria to approve its use this month without pre-approval from the WHO.